-

LZ Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into LegalZoom.com, Inc. (LZ)

LegalZoom.com beat on adjusted EPS at $0.16 while cutting its full-year revenue outlook by as much as $35 million. Levi & Korsinsky is investigating potential securities law violations on behalf of LZ investors who lost money.

NEW YORK--(BUSINESS WIRE)--LegalZoom.com, Inc. (NASDAQ: LZ) shares dropped after the Company's August 5 second-quarter release, in which adjusted earnings per share came in at $0.16 versus the $0.15 consensus -- while full-year revenue guidance was reduced to approximately $795 million to $805 million from $810 million to $830 million. If you lost money on LZ shares, click here to submit your information. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

The headline quarter looked fine. Revenue was approximately $205.3 million, essentially in line. Adjusted EPS beat. The forward numbers were another matter: third-quarter revenue was guided to approximately $194 million, below analyst estimates, and the full-year top end came down by $25 million.

Alongside those figures, LegalZoom announced a workforce reduction of roughly 13%. JPMorgan and William Blair each downgraded the stock following the release. Levi & Korsinsky is investigating potential securities law violations at LegalZoom.com, Inc.

Shareholders who purchased LZ and suffered a loss are encouraged to have their losses evaluated at no cost, or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Levi & Korsinsky, LLP -- Top 50 securities litigation firm (ISS, seven consecutive years). Over 70 professionals. Hundreds of millions recovered.

Frequently Asked Questions About the LZ Investigation

Q: What is the LZ securities investigation about? A: A securities investigation is pending concerning LegalZoom.com, Inc. (NASDAQ: LZ) regarding potentially materially false or misleading statements. Shares fell after the Company's August 5 release reduced full-year revenue guidance to approximately $795-$805 million from $810-$830 million and disclosed a roughly 13% workforce reduction, causing losses for shareholders.

Q: Who is eligible to participate in the LZ investigation? A: Investors who purchased LZ stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.

Q: When did LegalZoom.com allegedly mislead investors? A: The investigation concerns statements made before the August 5, 2026 corrective disclosure that allegedly caused investors to purchase securities at inflated prices.

Q: What do LZ investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at jlevi@levikorsinsky.com or (212) 363-7500. No immediate action is required to remain eligible to participate in the investigation.

Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What if I already sold my LZ shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought LZ and sold at a loss may still participate in the investigation.

Q: What does it cost me to participate? A: There is no upfront cost to participate. Securities investigations and any resulting actions are generally handled on a contingency basis. No upfront fees, no retainer, and no out-of-pocket costs.

Q: What if I live outside the United States? A: U.S. securities investigations generally cover purchases on U.S. exchanges regardless of the investor's country of residence.

Attorney Advertising. Prior results do not guarantee similar outcomes.

Contacts

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

Levi & Korsinsky, LLP

NASDAQ:LZ

Release Versions

Contacts

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

More News From Levi & Korsinsky, LLP

EXEL Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Exelixis (EXEL)

NEW YORK--(BUSINESS WIRE)--Exelixis (NASDAQ: EXEL) shares dropped in after-hours trading after the Company reported Q2 revenue of approximately $628.7 million, missing consensus estimates, and lowered and narrowed its full-year 2026 revenue outlook. If you suffered a loss on your Exelixis investment, you are encouraged to submit your information here. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. The revenue shortfall came alon...

EBS Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Emergent BioSolutions (EBS)

NEW YORK--(BUSINESS WIRE)--Emergent BioSolutions (NYSE: EBS) shareholders took losses after the Company disclosed a $191.3 million non-cash impairment on its NARCAN franchise, attributed to increased competition and pricing pressure in naloxone. If you suffered a loss on your Emergent BioSolutions investment, you are encouraged to click here to submit your information. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. NARCAN Nasal...

UTI Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Universal Technical Institute (UTI)

NEW YORK--(BUSINESS WIRE)--Universal Technical Institute (NYSE: UTI) shareholders absorbed a sharp selloff after the Company lowered its fiscal 2026 baseline adjusted EBITDA outlook to above $135 million, down from more than $155 million -- a reduction of roughly $20 million from the figure management had reaffirmed months earlier. Investors who lost money on UTI are encouraged to submit their loss information now. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com o...
Back to Newsroom